“Berkshire Hathaway, the investment company run by multibillionaire Warren Buffet, bought shares in drug companies AbbVie, Bristol-Myers Squibb, Merck and Pfizer between July and September, according to filings with the US regulator.” [Source: theguardian.com]
With an estimated net worth of more than $88 billion, Warren Buffett is one of the world’s richest people. He has close links to Amazon CEO Jeff Bezos (the world’s richest person) and JPMorgan Chase CEO Jamie Dimon, having formed a healthcare company with them in 2018, and has long been an investor in the chemical industry.
Buffett’s $5.7 billion investment in AbbVie, Bristol-Myers Squibb, Merck, and Pfizer suggests he hopes to profit massively from the coronavirus crisis. In addition to these firms, his Berkshire Hathaway investment company already owns shares in other drug companies such as Biogen, Johnson & Johnson, and Teva Pharmaceuticals.
The announcement of Buffett’s investment in Pfizer comes at a time when the company’s ‘genetic vaccine’ against the coronavirus is generating daily headlines around the world. Based on the use of ‘messenger RNA’ (mRNA), Pfizer’s vaccine uses technology that is still in the experimental stage. Associated with serious side-effects, the long-term results of this approach are currently completely uncontrollable. To learn about the dangers of fighting the coronavirus pandemic with this new class of vaccines, visit the Dr. Rath Education website.